Back to the drawing board: The FACTS 001 trial, a study to test whether tenofovir gel could prevent HIV infection, did not confirm the gel’s effectiveness. While these results are disappointing, USAID is supporting the development of many other promising solutions, including vaginal rings and long-acting injectables.
Tag archives for PEPFAR
The recent focus on Ebola in West Africa has reminded us of the need for strong and resilient health systems. USAID will continue to use innovative training models and make investments in building work forces and strengthening health systems in countries with high HIV burdens worldwide.
A new $200 million initiative by PEPFAR and CIFF will double the total number of children receiving life-saving ART across 10 priority African countries over the next two years, bringing us closer to achieving an AIDS-Free Generation.
With the commitment, innovative spirit, creativity and hard work of our partners, USAID is continuously using science and technology in unprecedented ways to make great strides toward an AIDS-free generation.
The stigma and discrimination faced by people living with HIV/AIDS continues to be a roadblock for access to critical prevention and care. Yet every day I see significant steps that are being taken to overcome this obstacle, especially efforts led by USAID.
To help address the needs of 50 million adolescents who are already married, USAID invested in programs through PEPFAR to reach more than 220,000 married adolescent girls in Ethiopia.